首页> 美国卫生研究院文献>Gastroenterology Research >Efficacy and Safety of Neostigmine and Decompressive Colonoscopy for Acute Colonic Pseudo-Obstruction: A Single-Center Analysis
【2h】

Efficacy and Safety of Neostigmine and Decompressive Colonoscopy for Acute Colonic Pseudo-Obstruction: A Single-Center Analysis

机译:Neostigmine和减压结肠镜检查对急性结肠伪梗阻的疗效和安全性:单中心分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute colonic pseudo-obstruction (ACPO) is characterized by acute colonic dilation in the absence of anatomical obstruction. Neostigmine is an acetylcholinesterase inhibitor recommended as first-line salvage therapy for uncomplicated ACPO. Decompressive colonoscopy is recommended if neostigmine is contraindicated or unsuccessful. There is a need to better characterize relative efficacy and factors impacting treatment choice. The aim of the study was to examine the use, efficacy, and safety of neostigmine and decompressive colonoscopy in the management of ACPO at a single academic center.
机译:急性结肠伪梗阻(ACPO)的特征在于在没有解剖阻塞的情况下急性结肠扩张。 Neostigmine是一种乙酰胆碱酯酶抑制剂,推荐作为简单的ACPO的一线救死治疗。如果Neostigmine禁忌或不成功,建议使用减压结肠镜检查。需要更好地表征相对疗效和影响治疗选择的因素。该研究的目的是探讨Neostigmine和Drecuctve的结肠镜检查在单个学术中心的ACPO管理中的使用,疗效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号